DelveInsight’s “Pharyngitis Market Insights, Epidemiology, and Market Forecast 2032“ report delivers an in-depth understanding of the Pharyngitis, epidemiology insights, Pharyngitis market trends, therapies, and key companies working in the Pharyngitis Market in the 7MM.
Pharyngitis Overview
Pharyngitis is the inflammation of the mucous membranes of the oropharynx. In most cases, the cause is an infection, either bacterial or viral. Other less common causes of pharyngitis include allergies, trauma, cancer, reflux, and certain toxins.
Pharyngitis Epidemiology Insights
About 50% to 80% of pharyngitis, or sore throat, symptoms are viral in origin and include a variety of viral pathogens
In 2010, there were 1.814 million emergency department visits for pharyngitis, of which 692,000 were for patients under the age of 15. Most cases of pharyngitis occur in children under the age of 5. Adults can also develop the disorder but at a lower rate. Globally, pharyngitis rates are very high chiefly in countries where antibiotics are overprescribed
Click here to learn more about the Pharyngitis Market Landscape
The Report Covers the Pharyngitis Epidemiology Segmented by:
Total Pharyngitis prevalent cases
Total Pharyngitis type specific prevalent cases
Total Pharyngitis diagnosed cases
Total Pharyngitis treatable cases
Pharyngitis Market Outlook
The Pheochromocytoma market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Pheochromocytoma market trends by analyzing the impact of current Pheochromocytoma therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of Pheochromocytoma market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Pheochromocytoma market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Pheochromocytoma market in 7MM is expected to witness a major change in the study period 2019-2032.
Key Companies Working in the Pharyngitis Market
Pfizer
Biotop AG
Bayer Pharmaceuticals
Sandoz Pharmaceuticals
Takeda Pharmaceuticals
Sanofi Pharmaceuticals
And many others
Pharyngitis Therapies Covered and Analyzed in the Report:-
Tantum Verde
Pharynga
Benzocaine
Flurbiprofen
And many others
Learn more about the Key Companies and Emerging Therapies in the Pharyngitis Market
Table of Contents
Key Insights
Pharyngitis Introduction
Executive Summary of Pharyngitis
Disease Background and Overview
Epidemiology and patient population
Pharyngitis Emerging Therapies
Pharyngitis Market Outlook
Market Access and Reimbursement of Therapies
Market Drivers
Market Barriers
Appendix
Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the report @ Pharyngitis Market Outlook
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services